Osaic Holdings
CGON icon

Osaic Holdings’s CG Oncology CGON Stock Holding History

Osaic Holdings’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$166K Sell
2,339
-146
-6% -$9.54K ﹤0.01% 4571
2026
Q1 		$168K Buy
2,485
+2,299
+1,236% +$130K ﹤0.01% 4282
2025
Q4 		$7.72K Buy
186
+15
+9% +$621 ﹤0.01% 6482
2025
Q3 		$6.89K Sell
171
-160
-48% -$4.65K ﹤0.01% 6579
2025
Q2 		$8.61K Buy
+331
New +$7.98K ﹤0.01% 6240
2025
Q1 		– Sell
-35
Closed -$1K – 7480
2024
Q4 		$1K Buy
+35
New +$1.2K ﹤0.01% 6847

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Osaic Holdings's CGON Position: Q2 2026 in Review

Osaic Holdings reduced its CG Oncology (CGON) stake by 5.9% in Q2 2026, selling an estimated $9.54K and leaving 2,339 shares worth $166K. The position accounts for ﹤0.01% of the portfolio, ranked #4571.

Osaic Holdings first reported a position in CGON in Q4 2024 and has held it in 6 quarters since. The position peaked at $168K in Q1 2026. 227 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • Osaic Holdings held 2,339 shares of CG Oncology worth $166K as of Q2 2026.
  • Osaic Holdings sold 146 CG Oncology shares in Q2 2026, an estimated $9.54K.
  • CG Oncology made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #4571 holding.
  • Osaic Holdings first reported a position in CG Oncology in Q4 2024 and has held it in 6 quarters since.
  • Osaic Holdings's CG Oncology position peaked at $168K in Q1 2026.
  • 227 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.